Annual report pursuant to Section 13 and 15(d)

Equity Method Investments - Summary of Financial Information (Details)

v3.22.1
Equity Method Investments - Summary of Financial Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Feb. 28, 2022
Feb. 28, 2021
Feb. 28, 2022
Feb. 28, 2021
Feb. 29, 2020
Schedule of Equity Method Investments [Line Items]          
Current assets $ 3,329.7 $ 3,044.5 $ 3,329.7 $ 3,044.5  
Current liabilities 2,698.8 1,269.1 2,698.8 1,269.1  
Noncontrolling interests 315.9 330.2 315.9 330.2  
Net sales 2,102.5 1,953.0 8,820.7 8,614.9 $ 8,343.5
Gross profit (loss) 1,132.6 993.7 4,707.3 4,466.0 4,151.9
Net income (loss)     1.0 2,031.8 21.4
Net income (loss) attributable to CBI 395.4 382.9 (40.4) 1,998.0 (11.8)
Canopy equity method investment          
Schedule of Equity Method Investments [Line Items]          
Current assets 1,573.3 1,706.6 1,573.3 1,706.6  
Noncurrent assets 3,419.2 3,251.5 3,419.2 3,251.5  
Current liabilities 189.3 273.7 189.3 273.7  
Noncurrent liabilities 1,470.4 1,308.8 1,470.4 1,308.8  
Noncontrolling interests $ 3.3 $ 179.0 3.3 179.0  
Net sales     444.3 378.6 290.2
Gross profit (loss)     (18.6) (14.1) 45.4
Net income (loss)     (274.3) (1,775.3) (327.0)
Net income (loss) attributable to CBI     $ 328.7 $ (1,750.0) $ (312.6)